News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,051 Results
Type
Article (39700)
Company Profile (248)
Press Release (659103)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204273)
Career Advice (2008)
Deals (35434)
Drug Delivery (95)
Drug Development (81045)
Employer Resources (172)
FDA (16184)
Job Trends (14860)
News (345313)
Policy (32545)
Tag
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49450)
ALS (88)
Alzheimer's disease (1378)
Antibody-drug conjugate (ADC) (124)
Approvals (16189)
Artificial intelligence (253)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11637)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (176)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (278)
Cancer (2256)
Cardiovascular disease (174)
Career advice (1677)
Career pathing (30)
CAR-T (151)
Cell therapy (422)
Cervical cancer (19)
Clinical research (65987)
Collaboration (832)
Company closure (1)
Compensation (533)
Complete response letters (19)
COVID-19 (2588)
CRISPR (40)
C-suite (241)
Cystic fibrosis (100)
Data (2205)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (270)
Diagnostics (6388)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86700)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112428)
Executive appointments (722)
FDA (17446)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (747)
Gene editing (104)
Generative AI (19)
Gene therapy (301)
GLP-1 (708)
Government (4416)
Grass and pollen (4)
Guidances (67)
Healthcare (18815)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (115)
Indications (29)
Infectious disease (2730)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16515)
IRA (40)
Job creations (3632)
Job search strategy (1423)
Kidney cancer (10)
Labor market (38)
Layoffs (467)
Leadership (17)
Legal (7912)
Liver cancer (75)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (304)
MASH (67)
Medical device (13378)
Medtech (13383)
Mergers & acquisitions (19463)
Metabolic disorders (685)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (88)
Neuropsychiatric disorders (27)
Neuroscience (1913)
NextGen: Class of 2025 (6512)
Non-profit (4480)
Now hiring (39)
Obesity (364)
Opinion (204)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (83)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (112)
Peanut (46)
People (57316)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20557)
Phase II (29057)
Phase III (21649)
Pipeline (1203)
Policy (139)
Postmarket research (2563)
Preclinical (8738)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5910)
Recruiting (65)
Regulatory (22285)
Reports (46)
Research institute (2321)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (130)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3576)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (29)
Vaccines (688)
Venture capitalists (41)
Weight loss (234)
Women's health (35)
Worklife (16)
Date
Today (143)
Last 7 days (899)
Last 30 days (2597)
Last 365 days (32760)
2025 (10703)
2024 (35223)
2023 (40082)
2022 (51178)
2021 (55717)
2020 (54099)
2019 (46554)
2018 (35034)
2017 (32135)
2016 (31502)
2015 (37558)
2014 (31328)
2013 (26356)
2012 (28576)
2011 (29269)
2010 (27339)
Location
Africa (718)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (37849)
Australia (6184)
California (6125)
Canada (2013)
China (523)
Colorado (266)
Connecticut (274)
Delaware (148)
Europe (81453)
Florida (911)
Georgia (206)
Idaho (57)
Illinois (535)
India (25)
Indiana (307)
Iowa (11)
Japan (162)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (895)
Massachusetts (4567)
Michigan (220)
Minnesota (390)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1726)
New Mexico (28)
New York (1745)
North Carolina (966)
North Dakota (8)
Northern California (2680)
Ohio (204)
Oklahoma (14)
Oregon (34)
Pennsylvania (1375)
Puerto Rico (12)
Rhode Island (33)
South America (1096)
South Carolina (23)
South Dakota (1)
Southern California (2300)
Tennessee (101)
Texas (906)
United States (23105)
Utah (180)
Virginia (145)
Washington D.C. (61)
Washington State (550)
West Virginia (3)
Wisconsin (54)
699,051 Results for "qiagen inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025
April 23, 2025
·
6 min read
Press Releases
QIAGEN Launches QIAprep& Plasmodium Kit to Strengthen Malaria Research and Surveillance Efforts
April 1, 2025
·
5 min read
Press Releases
QIAGEN Expands Its Digital PCR Portfolio With New Lentivirus Solutions to Strengthen Cell and Gene Therapy Quality Control
April 29, 2025
·
6 min read
Press Releases
QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results
March 31, 2025
·
3 min read
Press Releases
QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation
April 15, 2025
·
7 min read
Press Releases
QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast
April 8, 2025
·
1 min read
Press Releases
Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH
March 19, 2025
·
1 min read
Press Releases
QIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS Outlook
April 7, 2025
·
5 min read
Biotech Bay
QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs
QIAGEN announced the release of a new version of its clinical decision support software, QIAGEN Clinical Insight Interpret, that brings significant performance and scalability enhancements tailored for high-throughput, next-generation sequencing labs moving to larger test panels and higher test volumes.
June 13, 2024
·
7 min read
Press Releases
QIAGEN delivers solid Q4 2024 growth ahead of outlook
February 5, 2025
·
7 min read
1 of 69,906
Next
